Eurican Herpes 205

RSS

Canine herpes vaccine (inactivated subunit)

Authorised
This medicine is authorised for use in the European Union.

Overview

This is a summary of the European Public Assessment Report. Its purpose is to explain how the assessment done by the Committee for Medicinal Products for Veterinary Use (CVMP) on the basis of the documentation provided, led to the recommendations on the conditions of use.

This summary cannot replace a face-to-face discussion with your veterinarian. If you need more information about your animal’s medical condition or treatment, contact your veterinarian. If you want more information on the basis of the CVMP recommendations, read the Scientific Discussion (also part of the EPAR).

This EPAR was last updated on 17/06/2016

Authorisation details

Product details
Name
Eurican Herpes 205
Agency product number
EMEA/V/C/000059
Active substance
Canine herpesvirus (F205 strain) antigens
International non-proprietary name (INN) or common name
Canine herpes vaccine (inactivated subunit)
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) codes
QI07AA
Publication details
Marketing-authorisation holder
Merial
Revision
8
Date of issue of marketing authorisation valid throughout the European Union
26/03/2001
Contact address
29, avenue Tony Garnier
69007 Lyon
FRANCE

Product information

10/09/2015 Eurican Herpes 205 - EMEA/V/C/000059 - II/0017

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

IMMUNOLOGICALS FOR CANIDAE

Therapeutic indication

Active immunisation of bitches to prevent mortality, clinical signs and lesions in puppies resulting from canine herpes virus infections acquired in the first few days of life.

Assessment history

How useful was this page?

Add your rating